metaPreg - Liraglutide during pregnancy

Liraglutide updated on 01-05-2026

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
2 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	-	-	0 study					-
Large for gestational age (weight)	-	-	0 study					-
Small for gestational age (weight)	-	-	0 study					-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	-	-	0 study					-
Gestational diabetes	-	-	0 study					-
Preeclampsia	-	-	0 study					-